Report
Brian Han
EUR 100.00 For Business Accounts Only

API's Proposal to Merge with Sigma Could Deliver Synergies

We reduce our fair value estimate for narrow-moat Australian Pharmaceutical Industries, or API, to AUD 1.80 per share from AUD 1.95 following its weaker-than-expected fiscal 2018 result. Underlying net profit after tax of AUD 54.7 million, 0.9% up on the previous year, was 2% below our forecast. The miss was mostly top-line-driven, with group revenue of AUD 4.0 billion, falling 0.9% from last year. The revenue reduction was largely attributable to weaker demand for hepatitis C medicines, with re...
Underlying
Australian Pharmaceutical Industries Ltd

Australian Pharmaceutical Industry is a service provider to the pharmacy industry. Co. operates two segments, Australia and New Zealand. The Australia segment is engaged in the distribution of pharmaceutical, medical, health, beauty and lifestyle products to pharmacies, the purchase and sale of various health, beauty and lifestyle products within the retail industry and provider of retail services to pharmacies. The New Zealand segment is engaged as a manufacturer and owner of rights of pharmaceutical medicines and consumer toiletries.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Brian Han

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch